La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Youcare Pharmaceutical Group Croissance future
Future contrôle des critères 1/6
Youcare Pharmaceutical Group is forecast to grow revenue at 13.7% per annum.
Informations clés
n/a
Taux de croissance des bénéfices
n/a
Taux de croissance du BPA
| Pharmaceuticals croissance des bénéfices | 18.8% |
| Taux de croissance des recettes | 13.7% |
| Rendement futur des capitaux propres | n/a |
| Couverture par les analystes | Low |
| Dernière mise à jour | 31 Jan 2024 |
Mises à jour récentes de la croissance future
Pas de mise à jour
Recent updates
Youcare Pharmaceutical Group Co., Ltd.'s (SHSE:688658) Price Is Out Of Tune With Earnings
Aug 16
Youcare Pharmaceutical Group Co., Ltd. (SHSE:688658) Shares May Have Slumped 26% But Getting In Cheap Is Still Unlikely
Apr 21There's Reason For Concern Over Youcare Pharmaceutical Group Co., Ltd.'s (SHSE:688658) Massive 26% Price Jump
Mar 04Prévisions de croissance des bénéfices et des revenus
| Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
|---|---|---|---|---|---|
| 12/31/2025 | 5,118 | N/A | N/A | 448 | 1 |
| 12/31/2024 | 4,461 | N/A | N/A | 383 | 1 |
| 3/31/2024 | 4,036 | 169 | 232 | 714 | N/A |
| 12/31/2023 | 4,196 | 185 | 288 | 785 | N/A |
| 9/30/2023 | 3,998 | 152 | -164 | 393 | N/A |
| 6/30/2023 | 4,813 | 402 | -19 | 494 | N/A |
| 3/31/2023 | 4,770 | 357 | -350 | 129 | N/A |
| 12/31/2022 | 4,542 | 335 | -669 | -121 | N/A |
| 9/30/2022 | 5,123 | 507 | -299 | 212 | N/A |
| 6/30/2022 | 4,763 | 473 | -229 | 218 | N/A |
| 3/31/2022 | 4,987 | 539 | 138 | 490 | N/A |
| 12/31/2021 | 4,966 | 545 | 315 | 515 | N/A |
| 9/30/2021 | 4,879 | 562 | 550 | 702 | N/A |
| 6/30/2021 | 4,789 | 523 | 591 | 735 | N/A |
| 3/31/2021 | 4,481 | 476 | 509 | 638 | N/A |
| 12/31/2020 | 4,339 | 442 | 571 | 698 | N/A |
| 9/30/2020 | 4,096 | 358 | 412 | 498 | N/A |
| 12/31/2019 | 4,288 | 285 | 177 | 325 | N/A |
| 12/31/2018 | 3,983 | 268 | 19 | 193 | N/A |
| 12/31/2017 | 2,700 | 162 | N/A | 215 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: Insufficient data to determine if 688658's forecast earnings growth is above the savings rate (2.9%).
Bénéfices vs marché: Insufficient data to determine if 688658's earnings are forecast to grow faster than the CN market
Croissance élevée des bénéfices: Insufficient data to determine if 688658's earnings are expected to grow significantly over the next 3 years.
Chiffre d'affaires vs marché: 688658's revenue (13.7% per year) is forecast to grow faster than the CN market (13.4% per year).
Croissance élevée des revenus: 688658's revenue (13.7% per year) is forecast to grow slower than 20% per year.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Insufficient data to determine if 688658's Return on Equity is forecast to be high in 3 years time